Guardant Health (NASDAQ:GH) Given Outperform Rating at William Blair
William Blair reiterated their outperform rating on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. Other equities analysts also recently issued research reports about the company. Citigroup boosted their target price on Guardant Health from $40.00 to $50.00 and gave the company a […]